These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6183699)
101. [Interferons--its method of administration and adverse effect related to pharmacokinetics ]. Furue H Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804 [TBL] [Abstract][Full Text] [Related]
102. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon. Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433 [TBL] [Abstract][Full Text] [Related]
103. Interferon: pharmacokinetics and toxicity. Scott GM Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699 [TBL] [Abstract][Full Text] [Related]
104. Pharmacokinetics and side effects of interferon in man. Merigan TC Tex Rep Biol Med; 1977; 35():541-7. PubMed ID: 358475 [No Abstract] [Full Text] [Related]
105. Evaluation of routes of administration of interferon in cancer: a review and a proposal. Bocci V Cancer Drug Deliv; 1984; 1(4):337-51. PubMed ID: 6085757 [TBL] [Abstract][Full Text] [Related]
106. Interferon: mechanisms of action and clinical value. Houglum JE Clin Pharm; 1983; 2(1):20-8. PubMed ID: 6192965 [TBL] [Abstract][Full Text] [Related]
107. The pharmacology and toxicology of the interferons: an overview. Mannering GJ; Deloria LB Annu Rev Pharmacol Toxicol; 1986; 26():455-515. PubMed ID: 2424363 [TBL] [Abstract][Full Text] [Related]
109. Novel interferons for treatment of hepatitis C virus. Clark V; Nelson DR Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153 [TBL] [Abstract][Full Text] [Related]
111. [Interferon: facts and hopes. II. Interferon treatment]. DmoszyĆska-Giannopoulou A; Rupniewska ZM Pol Arch Med Wewn; 1981 Oct; 66(4):307-11. PubMed ID: 6174954 [No Abstract] [Full Text] [Related]
112. The chimpanzee as a model to test the side effects of human interferons. Schellekens H; de Reus A; vd Meide PH J Med Primatol; 1984; 13(5):235-45. PubMed ID: 6210368 [TBL] [Abstract][Full Text] [Related]
113. Interferon treatment of human neoplasia. Strander H Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561 [No Abstract] [Full Text] [Related]
114. Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C. Jansen PL; De Bruijne J Expert Opin Investig Drugs; 2012 Jan; 21(1):111-8. PubMed ID: 22126968 [TBL] [Abstract][Full Text] [Related]
115. Interferon: a changing picture. Larke RP Can Med Assoc J; 1966 Jan; 94(1):23-31. PubMed ID: 5322363 [TBL] [Abstract][Full Text] [Related]
116. Interferons: from molecular biology to man. Part 1. Genetics and molecular biology of the interferon system. Balkwill FR Microbiol Sci; 1986 Jul; 3(7):212-5. PubMed ID: 2484748 [TBL] [Abstract][Full Text] [Related]
117. Pharmacokinetic and pharmacological aspects of interferon therapy in man. Billiau A Acta Microbiol Acad Sci Hung; 1981; 28(3):257-62. PubMed ID: 6171139 [No Abstract] [Full Text] [Related]
118. Pharmacology and side-effects of interferons. Bocci V Antiviral Res; 1994 Jul; 24(2-3):111-9. PubMed ID: 7526785 [TBL] [Abstract][Full Text] [Related]